HOME >> 海外出版社刊 洋書販売 新着書籍 >>

Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics, 1E [PRINT ON DEMAND]

表紙見本写真

Elsevier

EditorCristina Nanni / Paolo Castellucci / Stefano Fanti / Neeta Pandit-Taskar

価格:13,200円 (本体 12,000円+税) 送料サービス

・Release: 2024

・ISBN: 9780443246340

・240 Pages

・Trim Size: 254 X 178 X 25.4 ・PRINT ON DEMAND

Description

In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.

Key Features

  • Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both; advantages of total body PET imaging in hematological malignancies; applications of FDG-PET imaging in leukemias; PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease; and more.
  • Provides in-depth clinical reviews on novel PET imaging techniques in the management of hematological malignancies, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Table of Contents

  • 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin's and Non-Hodgkin Lymphomas
  • New PET Tracers for Lymphoma
  • Radioligand Therapy in Lymphoma: Past, Present, and Future
  • Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities
  • FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence
  • New PET Tracers for Symptomatic Myeloma
  • Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both
  • Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia
  • Role of Novel Quantitative Imaging Techniques in Hematological Malignancies
  • Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment
  • PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking